Stock Price
188,800.00
Daily Change
-6,300.00 -3.23%
Monthly
-9.67%
Yearly
22.60%
Q2 Forecast
177,698.56

Celltrion reported KRW218.61M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.21M 131K Sep/2025
Celltrion KRW 218.61M 162.21K Dec/2025
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Moderna USD 391M 2M Sep/2025
Organon & Co USD 260.32M 333K Dec/2025
Revvity USD 111.8M 1.57M Mar/2026
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Viatris USD 1.16B 5.27M Mar/2026
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025